RCE in Advantech Iview
CVE-2022-2143
The affected product is vulnerable to two instances of command injection, which may allow an attacker to remotely execute arbitrary code.
Vulnerability class: Command Injection (OS Command Injection)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.603 (99.1th percentile), scored .
High probability of exploitation in the next 30 days — patch promptly. 99th percentile — 99.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.594 · newest: 0.603 · change: +0.009
Affected products
- Advantech Iview
- Advantech Iview — versions All
Weakness classification (CWE)
Public proof-of-concept exploits
References
- www.cisa.gov/uscert/ics/advisories/icsa-22-179-03 (US Government Resource, Third Party Advisory)
- packetstormsecurity.com/files/168108/Advantech-iView-NetworkServlet-Command-Inj… (Exploit, VDB Entry, Third Party Advisory)
Frequently asked questions
- What is CVE-2022-2143?
- CVE-2022-2143 is a critical-severity vulnerability in Advantech Iview, classified under Command Injection. CVSS score: 9.8/10. Published 2022-07-22.
- How severe is CVE-2022-2143?
- Critical severity. CVSS v3 base score is 9.8 out of 10.
- Is CVE-2022-2143 known to be exploited?
- 4 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.